AMPICILLIN TRIHYDRATE Drug Patent Profile
✉ Email this page to a colleague
When do Ampicillin Trihydrate patents expire, and when can generic versions of Ampicillin Trihydrate launch?
Ampicillin Trihydrate is a drug marketed by Aurobindo Pharma, Belcher Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Lederle, Mylan, Purepac Pharm, Sandoz, Strides Pharma, Vitarine, Dava Pharms Inc, and Teva. and is included in sixteen NDAs.
The generic ingredient in AMPICILLIN TRIHYDRATE is ampicillin/ampicillin trihydrate. Three suppliers are listed for this compound. Additional details are available on the ampicillin/ampicillin trihydrate profile page.
Summary for AMPICILLIN TRIHYDRATE
US Patents: | 0 |
Applicants: | 12 |
NDAs: | 16 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 66 |
Clinical Trials: | 1 |
Patent Applications: | 337 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMPICILLIN TRIHYDRATE at DailyMed |
Recent Clinical Trials for AMPICILLIN TRIHYDRATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Pharmacology for AMPICILLIN TRIHYDRATE
Drug Class | Penicillin-class Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for AMPICILLIN TRIHYDRATE
US Patents and Regulatory Information for AMPICILLIN TRIHYDRATE
AMPICILLIN TRIHYDRATE is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting AMPICILLIN TRIHYDRATE
COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷ Try a Trial